Skip to main content
Saturday, August 15, 2026
BTC $63,056 ▼ 0.40%
GOKHSHTEIN.
Live WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
More SectionsDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
Subscribe
Menu
NewsLive WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
MoreDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
Subscribe
LIVE
BTC$63,056down−0.40%ETH$1,880up+0.00%SOL$75.37down−0.60%XRP$1.01down−0.30%LINK$9.41up+7.20%ADA$0.180down−1.50%S&P 5007,786down−0.17%Nasdaq26,729down−0.28%Dow53,732down−0.20%RUT3,068up+0.51%TNX4.70%up+1.19%TYX5.27%up+1.00%FVX4.36%up+1.14%IRX3.70%down−0.22%VIX14.25down−2.60%GOLD$4,437.30up+0.38%SILVER$65.11up+0.18%OIL$82.40up+1.42%DXY99.64down−0.03%NVDA$225.16down−0.06%AAPL$305.93up+0.22%TSLA$342.27up+0.68%META$589.85down−0.86%MSFT$495.40down−0.30%AMZN$262.65down−0.94%GOOGL$345.90down−0.13%Fear & Greed34 — FearBTC$63,056down−0.40%ETH$1,880up+0.00%SOL$75.37down−0.60%XRP$1.01down−0.30%LINK$9.41up+7.20%ADA$0.180down−1.50%S&P 5007,786down−0.17%Nasdaq26,729down−0.28%Dow53,732down−0.20%RUT3,068up+0.51%TNX4.70%up+1.19%TYX5.27%up+1.00%FVX4.36%up+1.14%IRX3.70%down−0.22%VIX14.25down−2.60%GOLD$4,437.30up+0.38%SILVER$65.11up+0.18%OIL$82.40up+1.42%DXY99.64down−0.03%NVDA$225.16down−0.06%AAPL$305.93up+0.22%TSLA$342.27up+0.68%META$589.85down−0.86%MSFT$495.40down−0.30%AMZN$262.65down−0.94%GOOGL$345.90down−0.13%Fear & Greed34 — Fear
GOKHSHTEIN.
Media · Est. 2019
The front page of everything. Breaking news and sharp analysis across politics, markets, crypto, technology, and sports — with live market data built in.
Markets
Market OverviewDigital AssetsU.S. EquitiesMacro & RatesResearch
Editorial
Politics & PolicyTechnologySports BusinessResearch
Terminal
GMarketsGo PRO
Company
AboutContactEditorial StandardsCorrectionsAdvertiseSubscribe
Legal
Privacy PolicyTerms of ServiceDisclosures
© 2026 Gokhshtein Media. All rights reserved.
PrivacyTermsDisclosures
Tag

telehealth

3 articles

Hims & Hers Beats Revenue Estimates but Cuts Profit Forecast on Growth Spending
Research & Analysis4d ago
Hims & Hers Beats Revenue Estimates but Cuts Profit Forecast on Growth Spending
Q2 revenue of $753.2 million topped estimates by 7.8 percent, but a trimmed full-year adjusted EBITDA forecast sent shares down 9.7 percent.
Teladoc Faces Competitive Pressure as Growth Slows, Reimbursement Tightens
U.S. Equities89d ago
Teladoc Faces Competitive Pressure as Growth Slows, Reimbursement Tightens
Teladoc's stretched valuation and profitability challenges make it a risky bet as telehealth adoption normalizes
Hims & Hers Jumps on Peptide Reassessment: Multi-Billion Dollar Opportunity Unlocked
U.S. Equities121d ago
Hims & Hers Jumps on Peptide Reassessment: Multi-Billion Dollar Opportunity Unlocked
Hims & Hers Health, Inc. stock rallied sharply today after the U.S. government confirmed it would reassess the regulatory framework for popular peptides, signaling a substantial expansion opportunity for the telehealth provider.